Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Approval save search
Formosa Pharmaceuticals and AimMax Therapeutics Receive FDA Approval for Clobetasol Propionate Ophthalmic Suspension 0.05%, for the Treatment of Post-Operative Inflammation and Pain Following Ocular Surgery
Published: 2024-03-04 (Crawled : 23:00) - prnewswire.com
EYEN | $0.5897 8.68% 7.99% 770K
|
Health Technology
|
| O: -2.19%
H: 0.0%
C: -21.08%
fda ocular approval treatment pharmaceuticals therapeutics
Enbridge Receives Canada Energy Regulator Approval for Mainline Tolling Settlement
Published: 2024-03-04 (Crawled : 22:00) - prnewswire.com
ENB 3 d | $35.66 0.68% 0.39% 8M
|
Industrial Services
|
| O: 0.06%
H: 0.83%
C: 0.12%
energy approval canada
EPOW's “High-Energy Fast Charging Lithium Battery Graphite Anode Project” Secures Approval in Industrialization of Advanced Scientific and Technological Achievements
Published: 2024-03-04 (Crawled : 14:30) - globenewswire.com
EPOW | $0.7508 -4.4% 8.8K
|
Administrative and Support and ...
|
| O: 1.05%
H: 6.86%
C: -1.16%
charging lithium approval battery advanced
Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric Patients
Published: 2024-03-04 (Crawled : 13:30) - globenewswire.com
LNTH | $65.19 1.21% 1.2% 580K
|
Health Technology
|
| O: 0.56%
H: 1.88%
C: 0.55%
definity fda approval
J&J Wins Full FDA Approval for Rybrevant, Chemo Combo in NSCLC
Published: 2024-03-04 (Crawled : 13:30) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
fda approval
PepGen Announces Clearance of CTA by UK Medicines & Healthcare Products Regulatory Agency to Begin CONNECT2-EDO51, a Phase 2 Clinical Trial designed to support potential accelerated approval of PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy
Published: 2024-03-04 (Crawled : 12:00) - globenewswire.com
PEPG | $11.7 -0.17% -0.17% 20K
|
|
| O: 0.06%
H: 4.93%
C: 4.03%
edo51 approval treatment clearance trial potential duchenne
Boston Scientific Receives FDA Approval for the AGENT™ Drug-Coated Balloon
Published: 2024-03-01 (Crawled : 15:30) - biospace.com/
BSX | $72.91 5.68% -0.03% 15M
|
Health Technology
|
| O: 0.21%
H: 1.58%
C: 1.18%
fda approval
Mallinckrodt Announces U.S. FDA Approval of Supplemental New Drug Application for Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector
Published: 2024-03-01 (Crawled : 15:00) - biospace.com/
MNKKQ | $0.02
|
Manufacturing
| Email alert
Add to watchlist
MNK | $0.3402 -0.06% 540K
|
n/a
| Email alert
Add to watchlist
MNKPF | $17.25
|
n/a
| Email alert
Add to watchlist
MNKTQ | $0.12 -66.67% 39K
|
Manufacturing
| Email alert
Add to watchlist
acthar fda drug approval gel application
ATHA Energy Announces Approval to List on TSXV and Receipt of Final Order for Arrangement With Latitude Uranium
Published: 2024-03-01 (Crawled : 12:00) - globenewswire.com
NXE | $7.81 -0.13% 0.0% 2.3M
|
Non-Energy Minerals
|
| O: 0.14%
H: 12.18%
C: 9.35%
energy approval uranium order
EzFill Receives Approval from Three Miami Condo Associations to Offer Fueling to Residents of 600+ Units.
Published: 2024-02-29 (Crawled : 17:00) - globenewswire.com
EZFL | $2.39 -0.83% -0.84% 14K
|
|
| O: -5.18%
H: 13.66%
C: 0.0%
approval
NeuroBo Pharmaceuticals Receives First Site IRB Approval for Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity
Published: 2024-02-29 (Crawled : 13:00) - prnewswire.com
NRBO | $3.09 2.32% 2.27% 39K
|
Health Technology
|
| O: 9.32%
H: 6.66%
C: 3.45%
da-1726 obesity first approval treatment pharmaceuticals trial
Biosense Webster Announces CE Mark approval in Europe for VARIPULSE™ Pulsed Field Ablation (PFA) Platform
Published: 2024-02-29 (Crawled : 09:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.56%
H: 0.12%
C: -0.38%
europe approval platform
Court Provides Final Approval of Settlement with Direct Purchaser Class in the Multidistrict Antitrust Litigation; Final Court Approval Concludes the Antitrust Multidistrict Litigation
Published: 2024-02-29 (Crawled : 07:00) - prnewswire.com
INVVY | $21.8455 19.02% 8.1K
|
n/a
| Email alert
Add to watchlist
approval direct
Energem Corp. Announces Shareholder Approval of Business Combination with Graphjet Technology Sdn. Bhd.
Published: 2024-02-28 (Crawled : 21:00) - globenewswire.com
ENCP | $12.25 -0.41% 22K
|
n/a
|
| O: -8.71%
H: 5.28%
C: -6.22%
business approval technology
Powerfleet and MiX Telematics Receive Shareholder Approval for Proposed Business Combination
Published: 2024-02-28 (Crawled : 21:00) - prnewswire.com
MIXT | $14.55 0.0% 530K
|
Technology Services
|
| O: 1.56%
H: 0.41%
C: -1.95%
PWFL | $4.22 0.72% 0.71% 640K
|
Electronic Technology
|
| O: 1.27%
H: 0.63%
C: -0.63%
business approval
ATHA Energy Announces Latitude Uranium Obtains Shareholder Approval for Transaction
Published: 2024-02-28 (Crawled : 12:00) - globenewswire.com
NXE | $7.81 -0.13% 0.0% 2.3M
|
Non-Energy Minerals
|
| O: -0.55%
H: 0.56%
C: -3.33%
energy approval uranium
Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis
Published: 2024-02-26 (Crawled : 00:00) - biospace.com/
KZR | $0.8016 -2.95% -3.04% 420K
|
Health Technology
|
| O: 1.09%
H: 3.74%
C: -1.52%
lupus life approval sciences trial china
Rail Vision Sets New Safety Standards for Europe: Achieves Regulatory Approval and Certificate for Railway Operation in the EU
Published: 2024-02-26 (Crawled : 14:00) - globenewswire.com
RVSN | $1.1 0.0% 600K
|
n/a
|
| O: -2.07%
H: 5.99%
C: -6.34%
approval vision
Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira®
Published: 2024-02-24 (Crawled : 04:20) - globenewswire.com
KMDA | $5.16 1.18% 1.16% 11K
|
Health Technology
| Email alert
Add to watchlist
ALVO | $13.5 0.75% 0.74% 190K
|
n/a
| Email alert
Add to watchlist
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
simlandi first biosimilar approval teva
Textainer Announces Shareholder Approval of Its Pending Acquisition by Stonepeak and Receipt of Required Antitrust Approvals
Published: 2024-02-23 (Crawled : 12:30) - globenewswire.com
TGH | $49.99 0.0% 1.2M
|
Finance
|
| O: 0.46%
H: 0.0%
C: 0.0%
approval acquisition
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.